In our previous studies, tissues adjacent to early- and late-stage dysplasia, which in >90% of cases precede CRC tumors, were already found to show significantly increased levels of Rep+CD68+CD163+ MPs when compared to mucosal tissues of cancer-free individuals (Figure 5). This evidence concerns the gene CD68 and colorectal carcinoma.